Clinical and pathological analysis of 36 patients with benign and malignant lymphoepithelial lesions
Wei-min YE,Han-guang ZHU,Zhi-yuan ZHANG,Lai-ping ZHONG
DOI: https://doi.org/10.3969/j.issn.1672-3244.2007.03.007
2007-01-01
Abstract:PURPOSE: To analyze the clinical manifestation, diagnosis, treatment and prognosis of the patients with malignant lymphoepithelial lesion (MLEL), benign lymphoepithelial lesion (BLEL) and mucosa-associated lymphoid tissue lymphoma (MALToma), as well as their pathological characteristics and pathogenesis. METHODS: Thirteen patients with MLEL, 20 patients with BLEL, and 3 patients with MALToma were retrospectively reviewed with their clinical data, pathological data (hematoxylin and eosin stain, and immunohistochemistrical stain), and follow-up data. RESULTS: MLEL was characterized pathologically by clumps or strips of tumor cells with unclear margin and frequent nuclear mitosis among the large amounts of proliferated lymph tissues. Immunohistochemistrical results showed that all 13 cases were positive for CKpan, 3 out of 13 cases were positive for Vim, 2 out of 13 cases were positive for SMA; among the 8 patients who had been followed up for 3.5 months to 4 years, 1 patient died of local tumor recurrence, 1 patient died of other disease, 1 patient was alive with local tumor recurrence one year after primary surgery, and 5 patients were alive without tumor recurrence or metastasis. BLEL was characterized pathologically by atrophy of glandular substance, interstitial lymphocytes infiltration, and mild-shaped glandular myoepithelial islands. Immunohistochemistrical results showed that 19 cases were positive for CKpan, 17 cases were positive for LCA, 16 cases were positive for UCHL-1 and L26, 10 cases were positive for CK10, and 2 cases were positive for S-100; among the 12 patients who had been followed up for 3 months to 6 years, 1 patient died of other disease, 2 patients were alive with local tumor recurrence which was confirmed pathologically as MLEL after secondary surgical resection of the recurrent tumors, and the other patients were alive without tumor recurrence. Immunohistochemistrical results for MALToma showed that all 3 cases were positive for L26, LCA, CD79, and CD43, 2 cases were positive for either UCHL-1, or CKpan, or EMA; all 3 patients were still alive for at least 2 years, 1 patient had local tumor recurrence 6 months after primary surgery plus postoperative radiotherapy and then treated successfully by second surgery plus chemotherapy. CONCLUSION: From this study, MLEL is most often located in the parotid gland and more common in females than in males, it originates from salivary duct epithelium. Combined radical resection of primary lesion and neck dissection followed by postoperative radiotherapy is suggested for patients with MLEL and cervical lymph node metastasis. Local resection and close follow-up is suggested for patients with BLEL because of its potential transformation to MLEL. Surgical resection and proper postoperative chemotherapy is suggested for patients with MALToma, which is a subtype of B cell type lymphoma. Intraoperative frozen section is a reliable diagnostic method for these kinds of diseases. Supported by Shanghai Leading Academic Discipline Project(Grant No.Y0203).